Cita APA (7a ed.)

Martin, M., Ramos-Medina, R., Bernat, R., García-Saenz, J. A., Monte-Millan, M. d., Alvarez, E., . . . Lopez-Tarruella, S. (2021). Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts. Nature Portfolio.

Cita Chicago Style (17a ed.)

Martin, Miguel, et al. Activity of Docetaxel, Carboplatin, and Doxorubicin in Patient-derived Triple-negative Breast Cancer Xenografts. Nature Portfolio, 2021.

Cita MLA (8a ed.)

Martin, Miguel, et al. Activity of Docetaxel, Carboplatin, and Doxorubicin in Patient-derived Triple-negative Breast Cancer Xenografts. Nature Portfolio, 2021.